1. Home
  2. ITOS vs FSBW Comparison

ITOS vs FSBW Comparison

Compare ITOS & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • FSBW
  • Stock Information
  • Founded
  • ITOS 2011
  • FSBW 1936
  • Country
  • ITOS United States
  • FSBW United States
  • Employees
  • ITOS N/A
  • FSBW N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • FSBW Banks
  • Sector
  • ITOS Health Care
  • FSBW Finance
  • Exchange
  • ITOS Nasdaq
  • FSBW Nasdaq
  • Market Cap
  • ITOS 270.7M
  • FSBW 299.5M
  • IPO Year
  • ITOS 2020
  • FSBW 2012
  • Fundamental
  • Price
  • ITOS $10.02
  • FSBW $38.41
  • Analyst Decision
  • ITOS Hold
  • FSBW Hold
  • Analyst Count
  • ITOS 6
  • FSBW 1
  • Target Price
  • ITOS $10.60
  • FSBW $44.00
  • AVG Volume (30 Days)
  • ITOS 2.6M
  • FSBW 17.5K
  • Earning Date
  • ITOS 04-28-2025
  • FSBW 07-22-2025
  • Dividend Yield
  • ITOS N/A
  • FSBW 2.89%
  • EPS Growth
  • ITOS N/A
  • FSBW N/A
  • EPS
  • ITOS N/A
  • FSBW 4.31
  • Revenue
  • ITOS $35,000,000.00
  • FSBW $139,608,000.00
  • Revenue This Year
  • ITOS N/A
  • FSBW $8.34
  • Revenue Next Year
  • ITOS $31.74
  • FSBW $5.99
  • P/E Ratio
  • ITOS N/A
  • FSBW $8.91
  • Revenue Growth
  • ITOS 177.89
  • FSBW 0.22
  • 52 Week Low
  • ITOS $4.80
  • FSBW $31.46
  • 52 Week High
  • ITOS $18.13
  • FSBW $49.15
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 73.75
  • FSBW 44.21
  • Support Level
  • ITOS $8.30
  • FSBW $37.50
  • Resistance Level
  • ITOS $11.35
  • FSBW $39.27
  • Average True Range (ATR)
  • ITOS 0.53
  • FSBW 0.87
  • MACD
  • ITOS 0.22
  • FSBW -0.25
  • Stochastic Oscillator
  • ITOS 71.15
  • FSBW 23.33

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: